Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cancer Res ; 75(23): 5084-92, 2015 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-26627641

RESUMO

Treatment with ipilimumab improves overall survival (OS) in patients with metastatic melanoma. Because ipilimumab targets T lymphocytes and not the tumor itself, efficacy may be uniquely sensitive to immunomodulatory factors present at the time of treatment. We analyzed serum from patients with metastatic melanoma (247 of 273, 90.4%) randomly assigned to receive ipilimumab or gp100 peptide vaccine. We quantified candidate biomarkers at baseline and assessed the association of each using multivariate analyses. Results were confirmed in an independent cohort of similar patients (48 of 52, 92.3%) treated with ipilimumab. After controlling for baseline covariates, elevated chemokine (C-X-C motif) ligand 11 (CXCL11) and soluble MHC class I polypeptide-related chain A (sMICA) were associated with poor OS in ipilimumab-treated patients [log10 CXCL11: HR, 1.88; 95% confidence interval (CI), 1.14-3.12; P = 0.014; and log10 sMICA quadratic effect P = 0.066; sMICA (≥ 247 vs. 247): HR, 1.75; 95% CI, 1.02-3.01]. Multivariate analysis of an independent ipilimumab-treated cohort confirmed the association between log10 CXCL11 and OS (HR, 3.18; 95% CI, 1.13-8.95; P = 0.029), whereas sMICA was less strongly associated with OS [log10 sMICA quadratic effect P = 0.16; sMICA (≥ 247 vs. 247): HR, 1.48; 95% CI, 0.67-3.27]. High baseline CXCL11 and sMICA were associated with poor OS in patients with metastatic melanoma after ipilimumab treatment but not vaccine treatment. Thus, pretreatment CXCL11 and sMICA may represent predictors of survival benefit after ipilimumab treatment as well as therapeutic targets.


Assuntos
Anticorpos Monoclonais/uso terapêutico , Quimiocina CXCL11/sangue , Antígenos de Histocompatibilidade Classe I/sangue , Melanoma/sangue , Melanoma/tratamento farmacológico , Adulto , Idoso , Idoso de 80 Anos ou mais , Vacinas Anticâncer/uso terapêutico , Feminino , Humanos , Ipilimumab , Estimativa de Kaplan-Meier , Masculino , Melanoma/imunologia , Melanoma/patologia , Pessoa de Meia-Idade , Metástase Neoplásica , Taxa de Sobrevida , Adulto Jovem
2.
Cell Host Microbe ; 10(2): 97-104, 2011 Aug 18.
Artigo em Inglês | MEDLINE | ID: mdl-21843867

RESUMO

Alphaviruses, including several emerging human pathogens, are a large family of mosquito-borne viruses with Sindbis virus being a prototypical member of the genus. The host factor requirements and receptors for entry of this class of viruses remain obscure. Using a Drosophila system, we identified the divalent metal ion transporter natural resistance-associated macrophage protein (NRAMP) as a host cell surface molecule required for Sindbis virus binding and entry into Drosophila cells. Consequently, flies mutant for dNRAMP were protected from virus infection. NRAMP2, the ubiquitously expressed vertebrate homolog, mediated binding and infection of Sindbis virus into mammalian cells, and murine cells deficient for NRAMP2 were nonpermissive to infection. Alphavirus glycoprotein chimeras demonstrated that the requirement for NRAMP2 is at the level of Sindbis virus entry. Given the conserved structure of alphavirus glycoproteins, and the widespread use of transporters for viral entry, other alphaviruses may use conserved multipass membrane proteins for infection.


Assuntos
Proteínas de Transporte de Cátions/metabolismo , Proteínas de Drosophila/metabolismo , Drosophila/virologia , Receptores Virais/metabolismo , Sindbis virus/patogenicidade , Infecções por Alphavirus/metabolismo , Infecções por Alphavirus/virologia , Animais , Biotinilação/métodos , Proteínas de Transporte de Cátions/genética , Linhagem Celular , Culicidae , Proteínas de Drosophila/genética , Humanos , Imunoprecipitação , Ferro/farmacologia , Mamíferos , Camundongos , Interferência de RNA , Estabilidade de RNA , Sindbis virus/efeitos dos fármacos , Sindbis virus/genética , Transfecção , Vesiculovirus/genética , Vesiculovirus/metabolismo , Vesiculovirus/patogenicidade , Ligação Viral , Internalização do Vírus , Vírus do Nilo Ocidental/efeitos dos fármacos , Vírus do Nilo Ocidental/genética , Vírus do Nilo Ocidental/patogenicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA